Skip to main content
. 2024 Mar 18;17:1153–1170. doi: 10.2147/JPR.S452618

Table 2.

Frequency of Acupoint Application for CTS Treatment

NO. Acupoint Frequency
1 PC7 141 14.06%
2 PC6 122 12.16%
3 LI4 72 7.18%
4 TE5 64 6.38%
5 LI5 64 6.38%
6 LI11 46 4.59%
7 PC8 45 4.49%
8 TE4 43 4.29%
9 Ashi 37 3.69%
10 LI10 35 3.49%
11 LU10 31 3.09%
12 SI5 25 2.49%
13 HT7 23 2.29%
14 LU5 18 1.79%
15 LU8 18 1.79%
16 PC5 16 1.60%
17 EX-UE8 14 1.40%
18 PC3 12 1.20%
19 EX-UE9 11 1.10%
20 LU7 11 1.10%
21 LU9 11 1.10%
22 TE3 10 1.00%
23 LU6 9 0.90%
24 HT3 9 0.90%
25 SI4 8 0.80%
26 SP6 8 0.80%
27 EX-UE2 8 0.80%
28 PC4 7 0.70%
29 TE2 6 0.60%
30 LI6 6 0.60%
31 SI3 5 0.50%
32 TE10 5 0.50%
33 SI6 4 0.40%
34 HT8 3 0.30%
35 LR3 3 0.30%
36 LR4 3 0.30%
37 ST36 3 0.30%
38 SI8 3 0.30%
39 BL23 3 0.30%
40 LI12 3 0.30%
41 HT2 3 0.30%
42 Bizhong 3 0.30%
43 EX-UE11 3 0.30%
44 EX-UE10 3 0.30%
45 SI7 2 0.20%
46 HT5 2 0.20%
47 LI2 1 0.10%
48 LI3 1 0.10%
49 LI7 1 0.10%
50 LU11 1 0.10%
51 TE6 1 0.10%
52 BL13 1 0.10%
53 BL15 1 0.10%
54 GV3 1 0.10%
55 Shuiqu 1 0.10%
56 EX-B2 1 0.10%
57 LI8 1 0.10%
58 LI13 1 0.10%
59 LI8 1 0.10%
60 TE8 1 0.10%
61 TE9 1 0.10%
62 EX-LE11 1 0.10%
63 Wuhu 1 0.10%
64 ST24 1 0.10%
65 Shangfengshidian 1 0.10%
66 GV12 1 0.10%
67 GV11 1 0.10%
68 GV13 1 0.10%